ELE. V. Loskutova

E. V. Loskutova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


E. V. Loskutova has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of the efficacy of combination drugs in the treatment of broncho-obstructive syndrome in children

    by Kh. M. Vakhitov, A. V. Ishbuldina, L. F. Vakhitova, E. V. Loskutova, A. M. Zakirova, Zh. R. Ibragimova, E. V. Volyanyuk, I. N. Serdinskaya, E. V. Yazdani

    Introduction. Today, complex drugs are used as effective medications to relieve broncho-obstructive syndrome. Due to their composition, they can effectively influence mucociliary clearance, relieve bronchospasms, and improve sputum rheology. Aim. To conduct a comparative evaluation of the efficacy and safety of a complex mucolytic drug and other cough treatment options in children with broncho-obstructive syndrome. Materials and methods. A total of 167 children aged 3 to 15 years with obstructive bronchitis (mean age 7.9 ± 1.4 years) were observed. Children aged 4 to 8 years (91 children [54.5%]) represented the largest portion of the sample. The patients were divided into 2 groups: Group 1 (93 children) received Jocet® as their sole cough drug; Group 2, the control group (74 children), received a combination of mono-preparations: a bronchodilator combined with an expectorant and/or mucolytic drug. Results. The study investigated the safety profile of a complex mucolytic drug (Jocet®). The analysis of clinical observations showed no reported adverse events in 97% of patients, which evidenced high tolerability of the drug. On Days 6–7 of treatment, the severity of clinical symptoms in Group 1 was significantly lower than in Group 2. Group 1 also demonstrated faster improvement in auscultation findings and transformation of cough into productive wet cough; Group 2 showed a similar effect on average 0.9 days later. Conclusions. The use of Joсet® allowed to effectively and safely achieve the intended effect in children with broncho-obstructive syndrome as compared to children, who received a combination of drugs (a bronchodilator and an expectorant). Based on the study results, we would advise to include this drug in pediatric practice as an effective pathogenetic agent to treat obstructive bronchitis.

  • Peculiarities of peroxide homeostasis and cytokine status in children with community-acquired pneumonia of various etiologies

    by Yu. L. Mizernitsky, Kh. M. Vakhitov, A. V. Ishbuldina, E. V. Loskutova, L. F. Vakhitova, Ю. Л. Мизерницкий, Х. М. Вахитов

    Respiratory diseases in children occupy a leading position in the structure of childhood morbidity and are the focus of attention of pediatricians both due to their high prevalence and the high risk of developing complicated and chronic forms. An urgent task of modern pediatrics is to study not only the etiology, but also the pathogenetic mechanisms of the development of lower respiratory tract lesions due to the difficulties in diagnosis and the high risk of developing life-threatening conditions. Due to the special role of Streptococcus pneumoniae among pneumotropic pathogens, it was of interest to search for characteristic etiopathogenetic features of the development of pneumonias caused by this pathogen. Purpose. To study the activity of lipoperoxidation indicators, as well as the course of pro- and anti-inflammatory reactions by the level of cytokines in the peripheral blood in children with community-acquired pneumonia of various etiologies. Material and methods. The study included 129 children (58 boys and 71 girls) aged 5 to 17 years with various morphological variants of community-acquired pneumonia, who were divided into groups based on the etiology of the pathogen. All children had their levels of TNF-α, IL-1, IL-4, and IL-8 interleukins determined using ELISA, as well as their levels of malondialdehyde, antioxidant activity, and ceruloplasmin in their blood serum. Results. It was shown that 24.8% of the examined children had Streptococcus pneumoniae -induced pneumonia, with 84.3% of them showing clinically significant intoxication and respiratory disorders, and 65.6% showing a decrease in O2 saturation to 91–93%. This group also showed the highest values of pro-inflammatory cytokines, malondialdehyde, and the lowest values of total antioxidant activity and ceruloplasmin. The more subtle clinical symptoms of other types of viral pneumonia were accompanied by parallel increases in pro- and anti-inflammatory cytokines and less significant disturbances in peroxide homeostasis. Conclusions. Outpatient pneumococcal pneumonia is usually characterized by severe clinical course, high pro-inflammatory cytokine activity, and impaired peroxide homeostasis.

  • Clinical and etiological characteristics and cytokine profile in school-age children with community-acquired pneumonia

    by Yu. L. Mizernitsky, Kh. M. Vakhitov, G. F. Sitdikova, T. R. Safiullin, A. R. Nurmieva, E. V. Loskutova, Ю. Л. Мизерницкий, Х. М. Вахитов

    The urgent task of modern pediatrics is the study of the etiology and pathophysiology of community-acquired pneumonia in school-aged children due to difficulties in diagnosis and treatment, as well as the high risk of life-threatening complications and death.Purpose. To investigate the activity of pro-inflammatory and anti-inflammatory responses as measured by cytokine levels in the peripheral blood of children with community-acquired pneumococcal and non-pneumococcal pneumonia.Material and methods. The etiology of community-acquired pneumonia was confirmed by comparing the results of rapid testing of pneumococcus in urine and data from traditional bacteriological methods. The study included 118 children (57 boys and 61 girls) aged 7 to 16 years with various morphological variants of community-acquired pneumonia, which were divided into 2 groups. The first group included 28 children with pneumococcal etiology of community-acquired pneumonia, and the second group included 90 patients with non-pneumococcal community-acquired pneumonia. Levels of interleukins IL-1, IL-4, IL-8 and TNF-α were determined in all children by enzyme immunoassays.Results. In the etiology of community-acquired pneumonia in school-age children, atypical pathogens are responsible for more than 50% of cases. The clinical effectiveness of rapid testing of pneumococcal antigens in urine has been shown, and their use in routine pediatric practice has made it possible to timely identify a group of severe community-acquired pneumonia and reasonably prescribe antibacterial medications. It has been demonstrated that pneumococcal-induced pneumonia is characterized by higher levels of proinflammatory cytokines. These levels, along with the clinical course of the disease, confirm the high level of systemic inflammation. Relatively lower levels of proinflammatory cytokines corresponded to a more mild clinical picture of community-acquired pneumonia of non-pneumococcal etiology, which on the one hand may reflect a relatively «balanced» inflammatory response, and on the other hand determine the protracted and polyclinic course of the infectious process.Conclusion. The etiology of community-acquired pneumonia in school-age children is dominated by atypical pathogens. Community-acquired pneumonia of pneumococcal etiology has more severe clinical courses, and their early identification will allow for the appropriate prescription of initial antibacterial treatment.


  • The potential for predicting neonatal disabilities in preterm infants

    by E. V. Loskutova, Kh. M. Vakhitov, G. F. Sitdikova, N. R. Valieva, E. V. Volyanuk, L. F. Vakhitova, E. V. Yazdani, Х. М. Вахитов

    The urgent task of modern pediatricians and neonatologists is to predict the course of the early neonatal period, during which the basic adaptive mechanisms of newborn children are in an unstable state. This is particularly important for the study of premature newborns, who are at high risk for an unfavorable outcome.Purpose. The aim of this study was to investigate the nature of early neonatal adaptation in children born between 32- and 36-weeks’ gestation, from mothers with burdened obstetric and gynecological histories and concomitant medical conditions.Material and methods. Out of 75 patients, we divided children born against a background of placental abruption and pre-eclampsia into separate groups. We provide a comparative analysis of their obstetric, gynecological, and medical histories, as well as their pre-dictive factors, somatic status dynamics, and laboratory and instrumental examinationsResults. Analysis of the data showed that in late preterm newborns, the presence of placental abruption in the history of 100% of cases led to the development of general somatic distress, with deterioration in hemodynamic and respiratory parameters, requiring transfer to the second phase of care. In children born preterm due to severe preeclampsia or other causes, stable severe conditions were observed in 33.3 and 39.6%, respectively, and 53.9 to 60% of infants required respiratory support.Conclusion. These findings allow for individualized assessment of a newborn’s condition in the first few days of life, based on predictive factors that may lead to a breakdown in compensatory responses.

  • Open Access

    The influence of cytokine reactions on the nature of the course of adaptive mechanisms in newborns of different gestational ages

    by Kh. M. Vakhitov, E. V. Loskutova, L. F. Vakhitova, G. F. Sitdikova, Х. М. Вахитов

    Introduction. The study of the mechanisms of adaptation and consequences of deadaptation in newborns, and especially premature babies in the first days of life is an integral part of neonatal practice. The cytokine system is considered as sensitive and informative indicators of homeostatic disorders in newborns of different gestational ages.Aim. To assess the features of the early neonatal period in newborns of different gestational ages according to the nature of changes in the levels of interleukin-1, -4, -8 in the cord blood and on the 3-4th day of the infant's life.Materials and methods. 108 newborns were examined, of which 64 premature infants of the gestational age of 32 (0/7) - 36 (6/7) weeks were included in the treatment group: moderately premature infants (32 (0/7) - 33 (6/7) weeks) and late premature infants (34 (0/7) - 36 (6/7) weeks). The control group included 44 conditionally healthy full-term infants born between 37 (0/7) and 41 (6/7) week of gestation: early full-term (37 (0/7) - 38 (6/7) weeks) and full-term intants (more than 39 (0/7) weeks).Results and discussion. The full-term infants, as well as late premature infants, whose clinical status was assessed as satisfactory, usually showed minimum levels of all studied cytokines. If the early neonatal period was complicated, high levels of interleukin-1 and -8 with underlying slightly elevated levels of anti-inflammatory interleukin-4 were observed. This fact supports the activation of cytokine reactions during manifestation of pathological symptom groups generated by various organs and systems in the early neonatal period.Conclusion. The nature of cytokine reactions can serve as a marker of unfavourable course of the early neonatal period in premature infants and a criterion that justifies the implementation of necessary corrective measures.

  • Open Access

    Interferon inductors: clinical efficacy and regulation of inflammatory responses in paediatric respiratory infections

    by Kh. M. Vakhitov, G. F. Sitdikova, E. V. Loskutova, L. F. Vakhitova, I. N. Serdinskaya, Х. М. Вахитов

    Introduction. The study of the set of mechanisms of inflammation regulation plays an important role in shaping understanding of the local and general protective and adaptive processes in paediatric respiratory infections. The cytokine system is taken as universal, pleiotropic regulators of the cascade of inflammatory, immune and metabolic processes. Nowadays, the drugs with the potential for effecting the course of cytokine reactions are of great interest.Aim. To evaluate the efficacy of the impact of low molecular weight interferon inducers with a wide range of biological activity on the severity of clinical symptoms and the level of pro- and anti-inflammatory cytokines of peripheral blood in paediatric respiratory infections.Materials and methods. 98 children with ARVI aged 4 to 11 years were examined, of which 57 children received meglumine acridone acetate as etiotropic antiviral therapy at recommended age-related doses and were included in the treatment group. 41 children receiving only symptomatic treatment were included in the comparison group.Results and discussions. Clinically, the use of meglumine acridone acetate resulted in decreased duration of the major symptoms of acute viral respiratory infections among children, reduced risk of complications, and decreased inflammatory manifestations. It was shown that the minimum levels of interleukin-1, -4 and -8 were typical for healthy children, which confirmed the activation of cytokine reactions only in the process of development of pathological symptoms from various organs and systems. An increase in all the studied cytokine levels was observed in ARVI, while the dominance in growth of pro-inflammatory cytokines with underlying slightly increased level of anti-inflammatory interleukin-4 was observed in severe general toxic syndrome and catarrhal signs. In similar cases, a balanced decrease in the levels of anti- and pro-inflammatory cytokines and a relatively rapid regression of clinical symptoms was noted during the meglumine acridone acetate therapy.Conclusions. The use of meglumine acridone acetate contributes to the rapid relief of the major clinical symptoms of acute respiratory viral infections, and shortens the duration of the disease. The nature of cytokine reactions can serve as a marker of an unfavourable course of ARVI. The prescription of low-molecular interferon inducers balances an increase in the levels of pro- and anti-inflammatory cytokines of peripheral blood.